A newly discovered function for the ApoE4 gene, the strongest genetic risk factor for Alzheimer’s disease, may help explain how the gene causes cognitive decline.
A stroke education program that uses hip hop music increased stroke awareness among economically disadvantaged minority children and their parents.
Researchers from two Columbia University campuses have teamed up to develop a football helmet that detects concussion in real time.
Clinical trial shows that solanezumab, an antibody-based treatment for Alzheimer’s disease, does not significantly slow cognitive decline.
Columbia neurologists and engineers are using a robotic device to investigate how Parkinson’s affects the ability to walk and respond to balance perturbations.
A community wellness center led by two P&S faculty members will strengthen initiatives in stroke prevention and mental health support.